In last trading session, Altimmune Inc (NASDAQ:ALT) saw 2.19 million shares changing hands with its beta currently measuring 0.60. Company’s recent per share price level of $5.70 trading at -$0.06 or -1.04% at ring of the bell on the day assigns it a market valuation of $467.18M. That closing price of ALT’s stock is at a discount of -95.79% from its 52-week high price of $11.16 and is indicating a premium of 37.72% from its 52-week low price of $3.55. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.93 million shares which gives us an average trading volume of 2.65 million if we extend that period to 3-months.
For Altimmune Inc (ALT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.20. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Altimmune Inc (NASDAQ:ALT) trade information
Upright in the red during last session for losing -1.04%, in the last five days ALT remained trading in the green while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $5.70 price level, adding 7.01% to its value on the day. Altimmune Inc’s shares saw a change of -20.94% in year-to-date performance and have moved 6.34% in past 5-day. Altimmune Inc (NASDAQ:ALT) showed a performance of 23.11% in past 30-days. Number of shares sold short was 22.58 million shares which calculate 10.37 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 77.2% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -110.53% in reaching the projected high whereas dropping to the targeted low would mean a loss of -110.53% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 3.48% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 7.78% while estimates for its earnings growth in next 5 years are of 3.40%.
Altimmune Inc (NASDAQ:ALT)’s Major holders
Insiders are in possession of 0.80% of company’s total shares while institution are holding 53.72 percent of that, with stock having share float percentage of 54.15%. Investors also watch the number of corporate investors in a company very closely, which is 53.72% institutions for Altimmune Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at ALT for having 5.32 million shares of worth $35.39 million. And as of 2024-06-30, it was holding 7.5025 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.91 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9181 of outstanding shares, having a total worth of $32.63 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.24 shares of worth $12.75 million or 2.90% of the total outstanding shares. The later fund manager was in possession of 1.91 shares on Mar 31, 2025 , making its stake of worth around $10.91 million in the company or a holder of 2.49% of company’s stock.
